A group based on complementary expertise with multidisciplinary know-how

Biotech investissement

A range of integrated biotechnology solutions

Custom Products & Services in Biotechnology

Molecular Biology - Immunology - Protein and Cell Engineering

Monoclonal antibodies, Cytokines, Chemokines, CD markers, Apoptosis, Bioactive antibodies, ELISA Kits, ELISpot Kits, DIAplex, Bioassays

go

Custom services, Biomanufacturing and purification, antibodies, recombinant proteins, plasmids, transfection, hybridoma development, expression vectors, FastELISA kits

go

Primary and Secondary Antibodies Anti-species, Isotype controls, custom services, hybridoma development – rat, guinea pig, murine, Immunoassays

go

Effective synergy

As part of a team of experts to ensure:

  • The development of new biological tools in immunology, molecular biology, cellular engineering
  • Identification of new markers
  • The development of analytical methods
  • Scientific and technical support
  • The quality of services and products developed and manufactured in-house

Main sectors of activity

  • Pharmaceutical
  • BioTherapeutics
  • Biotechnology
  • In vitro diagnostics
  • Animal health
  • Dermo-cosmetic
  • Agribusiness
  • Life sciences
  • Environment
  • Research Institutes

News

  • POLEPHARMA Bioproduction Seminar – 3rd Edition
    Date of publication : 27/11/2018

    Biotech Investissement participates in the 3rd edition of the congress “Polepharma BIOPRODUCTION” in Tours (France) with RD-BIOTECH and...

    Read more
  • 2nd Congress I4ID 2018
    Date of publication : 27/11/2018

    Biotech Investissement participates in the 2nd congress “Immunotherapies for Infectious diseases” (I4ID2018) in Lyon (France) with RD-BIOTECH and DIACLONE

    https://i4id.org/

    Come and...

    Read more
  • QVQ joins the Biotech Investissement Group
    Date of publication : 12/10/2018

    Dear Customers and Partners

    We are pleased to announce that QVQ, a company based in Utrecht (The Netherlands), is now a sister company of RD-Biotech SAS, Diaclone SAS and SynAbs SA (Biotech...

    Read more